Tony Blau, MD
As the co-founder of Partners in Personal Oncology, Tony Blau, MD, remains committed to patient-centered cancer care. Partners in Personal Oncology offers highly motivated cancer patients an alternative treatment that involves genetic testing, collecting tumor specimens, introducing patients to clinical trials considered advantageous for their treatment plans, and testing specimens using the most state-of-the-art technology available. Aside from Partners in Personal Oncology, Dr. Tony Blau functions as a Professor of Medicine for the Division of Hematology at the University of Washington (UW). He also serves as an Adjunct Professor of Genome Sciences and as a Co-Director of the Institute of Stem Cell and Regenerative Medicine for the school.
Dr. Tony Blau has worked with several graduate students and fellows as research trainees, and he participates in several ongoing research projects such as “Modeling the Three Dimensional Architecture of Genomes,” “Developing Systems Biology Approaches for Understanding and Treating Acute Myeloid Leukemia,” and “Capturing the Subclonal Heterogeneity of Cancer.” In this last project, Dr. Blau works with Bill Noble and Junfeng Wang to develop an instrument that will allow oncologists a closer look at the mutational content and size of sub-clones in a given patient's cancer, enabling the oncologist to track and attack resistant sub-clones. Dr. Tony Blau hopes this project will eventually open the door for doctors to preemptively treat tumors and allow oncologists to anticipate paths of resistance, which could decrease the number of recurrent cancer cases in patients around the world.
Dr. Tony Blau graduated summa cum laude from Wright State University and obtained his Doctor of Medicine at Ohio State University. Dr. Blau completed his residency at Duke University's Department of Medicine and served as a Senior Fellow in the Division of Oncology at UW.